This message contains images. If you don't see images, click here to view.
Click
here to advertise in this news brief.
Advertisement
|
|
Advertisement
Advertisement
|
|
Advertisement
The prognostic value of kidney transplant center report cards
American Journal of Transplantation (login required)
SRTR report cards provide the basis for quality measurement of U.S. transplant centers. There is limited data evaluating the prognostic value of report cards, informing whether they are predictive of prospective patient outcomes. Using national SRTR data, researchers have simulated report cards and calculated standardized mortality ratios (SMR) for kidney transplant centers over five distinct eras.
Advertisement
Free UNOS webinar series on new living kidney donor policy requirements
- Aug. 21: The Living Kidney Donor: OPTN Requirements for Medical and Psychosocial Evaluations Registration is open!
- Nov. 6: OPTN Requirements for Living Kidney Donor Follow Up
CEPTC credit is available. All webinars are 2-3 p.m. ET. Click here for more information and to register for the Aug. 21 webinar. For questions, contact Kim Johnson, MS, Instructional Innovations Coordinator, at (804) 782-4654 or kim.johnson@unos.org.
Advertisement
PRODUCT SHOWCASE
 |
|
The University Of Utah Department Of Surgery is seeking applications for a faculty member to join the multi-organ transplant team at the assistant professor level. This is an opportunity to join an expanding program and a cohesive group of transplant surgeons focused on excellence. The candidate should be board certified in general surgery and have completed an ASTS approved transplantation surgery fellowship. Apply here
|
|
Revised cardiac risk index is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients
Transplantation (login required)
Researchers recently evaluated a published Revised Cardiac Risk Index to determine if this preoperative cardiovascular risk stratification tool would be useful in the kidney transplant recipient population.
Organ allocation: What is just and fair?
By Dorothy L. Tengler
 The Cleveland Clinic will be holding a conference on Emerging Issues in Organ Transplantation on Sept. 23-24 at Kiawah Island, S.C., focusing on current issues that are in various states of transition. One such issue is organ allocation, a topic that raises some serious questions about ethics and best practices in a field that is already fraught with tension over life-and-death decisions.
Excellent liver retransplantation outcomes in hepatitis C-infected recipients
Clinical Transplantation (login required)
Survival outcomes for liver retransplantation (LRTx) after graft loss in HCV patients (HCV-LRTx) are generally considered inferior to those after non-HCV-LRTx. Between January 1, 2005 and June 30, 2011, 663 LTx were performed, including 116 (17.5 percent) LRTx, 41 (35.3 percent) of which were more than 90 d after the LTx. Twenty-nine (70.7 percent) LRTx were performed in HCV antibody–positive individuals.
|
Advertisement
|
 |
|
Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. For more information about Astellas Pharma US, Inc., please visit our Web site at www.astellas.us
|
|
Advertisement
|
 |
|
LIFECODES is introducing its new HLA-SSO kits. The new kit includes a validated, high-performance enzyme for improved reliability and performance with the continued ease of no centrifugation or wash steps; providing accurate, clear and easy to interpret results.
|
|
|
|
|
 |
|
|
The FlowSight offers high performance in a small package. Its innovative design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Twelve standard detection channels simultaneously produce brightfield, darkfield and up to ten channels of fluorescence imagery of every cell. More info
|
|
| Advertisement
|
Advertisement
Transplant IV Biologics and Oral Immunosuppressives specializing in Desensitization and AMR Treatment and Prevention. MORE
|
|
Trial: Conversion from twice-Daily tacrolimus capsules to once-daily extended-release tacrolimus
Transplantation
LCP-Tacro is an extended-release formulation of tacrolimus designed for once-daily dosing. Phase 1 studies demonstrated greater bioavailability to twice-daily tacrolimus capsules and no new safety concerns.
Mesenchymal stem cells in organ transplantation
By Maria Frisch
In October of 2012, the Mesenchymal Stem Cells Solid Organ Transplantation (MiSOT) Consortium met to review the current state of clinical data. In June, they released a position paper that reviewed the safety and efficacy of mesenchymal stem cells (MCS) as a therapeutic agent in solid organ transplantation. This article has been adapted from that position paper to present the clinically applicable highlights and to summarize what you need to know for your practice.
Missed last week's issue? See which articles your colleagues read most.
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation
Pediatric Transplantation (login required)
FNH is a non-malignant neoplasia of the liver rarely described in children. A significant percentage of the pediatric cases have been reported in patients with a history of malignant disease treated with chemo-radiation therapy and in children who were given HSCT. Little is known about the pathogenesis of FNH in transplanted children, but many risk factors linked to the HSCT procedure have been hypothesized. The detection of hepatic nodules, particularly in children who underwent HSCT for a previous malignancy, always raises a diagnostic dilemma. To help the physicians in the diagnostic management of this rare entity, researchers have retrospectively evaluated a series of transplanted children diagnosed with FNH.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
Mobile version
